Contrafect

Developer of therapeutics for the treatment of antibiotic-resistant infections

placeYonkers, New York, United States calendar_todayFounded 2008 groups23 employees language contrafect.com

Registered entities

Innovation

31 patent families (11 granted) — focus: Human necessities, Chemistry & metallurgy, Emerging technologies; filing pace slowing. Cited 3,438 times.

YearFilings
20143
20155
20164
20178
20186
201911
202020
202122
202217
202317
20248
20256

Investor mix

7 investors on record; lead investors include Maxim Group.

Investor typeCountShare
Venture capital114%
Private equity114%
Bank & private debt114%
Other / undisclosed457%
Coming soon